Articles From: Endo to buy Auxilium in $2.6 billion deal to Endurance Specialty Holding, Ltd. Transitions Policy Administration and Rating Systems to Accenture Duck Creek Software


By Chelsey Dulaney Endo International PLC on Thursday said it has agreed to buy Auxilium Pharmaceuticals Inc. in a cash-and-stock deal valued at about $2.6 billion, after the Dublin-based company's $2.2 billion offer for Auxilium was rejected last month.
Sign-up for Endo to buy Auxilium in $2.6 billion deal investment picks
DUBLIN , Sept.
Sign-up for Endo to Present at Morgan Stanley Global Healthcare Conference 2014 investment picks
Endo International (ENDP) said Monday it believes its buyout offer for Auxilium Pharmaceuticals' (AUXL) is "compelling," and provides a "substantial premium and immediate cash value" for Auxilium shareholders.
Sign-up for Endo: Buyout offer for Auxilium 'compelling,' provides 'substantial premium' investment picks
2014/8/22
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1139786&ProfileId=051205&sourceType=1 NEW ORLEANS, LA --
Sign-up for ENDOCYTE 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against Endocyte, Inc. - ECYT investment picks
WEST LAFAYETTE, Ind., Aug.
Sign-up for Endocyte Announces Presentations at the 248th American Chemical Society National Meeting & Exposition investment picks
WEST LAFAYETTE, Ind., July 22, 2014 (GLOBE NEWSWIRE) -- Endocyte, Inc., (Nasdaq:ECYT) announced today that the company will host a conference call on Tuesday, July 29, at 4:30 p.m. EDT to discuss its second quarter 2014 financial results and provide an operational update.
Sign-up for Endocyte Announces Second Quarter 2014 Earnings Conference Call investment picks
– EC1456 Targeting Potent Tubulysin Payload to Advance in Phase 1 to Dose Similar to Vintafolide – WEST LAFAYETTE, Ind., July 29, 2014 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) , a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced financial results for the second quarter ending June 30, 2014, and provided a clinical update.
Sign-up for Endocyte Reports Second Quarter Financial Results and Provides Clinical Update investment picks
WEST LAFAYETTE, Ind., Aug.
Sign-up for Endocyte Scientific Team Selected to Receive 2015 George and Christine Sosnovsky Award for Cancer Research investment picks
WEST LAFAYETTE, Ind., Aug.
Sign-up for Endocyte to Present at the Baird 2014 Health Care Conference investment picks
WEST LAFAYETTE, Ind., Aug.
Sign-up for Endocyte to Present at Wedbush 2014 Life Sciences Management Access Conference investment picks
IRVINE, Calif., Sept.
Sign-up for Endologix Announces Preliminary Third Quarter 2014 Revenue and Updates Financial Guidance investment picks
IRVINE, Calif., Sept.
Sign-up for Endologix Completes Enrollment in EVAS FORWARD - Global Registry investment picks
IRVINE, Calif., July 30, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX) , developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and six months ended June 30, 2014.
Sign-up for Endologix Reports 13% Global Revenue Growth for the Second Quarter 2014 investment picks
LEOPARD Study to Enroll 600 Patients to Provide a "Real-World" Head-to-Head Comparison of the AFX® System Versus Other Commercially Available EVAR Devices IRVINE, Calif., Sept.
Sign-up for Endologix to Initiate First Ever Comparative Randomized EVAR Study investment picks
IRVINE, Calif., Aug.
Sign-up for Endologix to Present at Canaccord Genuity 34th Annual Growth Conference investment picks
IRVINE, Calif., July 16, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX) , developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its second quarter 2014 financial results, which will take place on Wednesday, July 30, 2014 after the close of the market.
Sign-up for Endologix to Report Second Quarter 2014 Financial Results on July 30, 2014 investment picks
IRVINE, Calif., Oct.
Sign-up for Endologix to Report Third Quarter 2014 Financial Results on October 30, 2014 investment picks
Endurance International Group (NASDAQ: EIGI), a leading provider of cloud-based platform solutions designed to help small and medium-sized businesses succeed online, today announced the appointment of Alan Wallace as Director of Public Relations.
Sign-up for Endurance Announces Alan Wallace as Director of Public Relations investment picks
Bluehost, FatCow and A Small Orange to Raise Money for Local and National Charities BURLINGTON, Mass.
Sign-up for Endurance Gives Back During the Month of October investment picks
Talent is needed in Houston, Texas and Orem, Utah for HostGator and Bluehost BURLINGTON, Mass.
Sign-up for Endurance International Group Is Hiring investment picks
BURLINGTON, Mass., Aug.
Sign-up for Endurance International Group Reports 2014 Second Quarter Results investment picks
BURLINGTON, Mass., July 10, 2014 (GLOBE NEWSWIRE) -- Endurance International Group Holdings, Inc. (Nasdaq:EIGI) , a leading provider of cloud-based platform solutions designed to help small and medium-sized businesses succeed online, announced today that it will report its 2014 second quarter financial results on Thursday, August 7, 2014.
Sign-up for Endurance International Group to Announce 2014 Second Quarter Financial Results on August 7, 2014 investment picks
BURLINGTON, Mass., Oct.
Sign-up for Endurance International Group to Announce 2014 Third Quarter Financial Results on November 4, 2014 investment picks
BURLINGTON, Mass., Sept.
Sign-up for Endurance International Group to Present at the Goldman Sachs 23rd Annual Communacopia Conference investment picks
BURLINGTON, Mass., July 24, 2014 (GLOBE NEWSWIRE) -- Endurance International Group Holdings, Inc. (Nasdaq:EIGI) , a leading provider of cloud-based platform solutions designed to help small and medium-sized businesses succeed online, today announced that Hari Ravichandran, chief executive officer and founder, and Tivanka Ellawala, chief financial officer, will present at the Oppenheimer 17 th Annual Technology, Internet & Communications Conference in Boston on Tuesday, August 12, 2014 at 1:05 p.m. ET.
Sign-up for Endurance International Group to Present at the Oppenheimer 17th Annual Technology, Internet & Communications Conference investment picks
Endurance International Group (NASDAQ: EIGI), a leading cloud-based platform solutions provider helping small and medium-sized businesses succeed online, announced today that it has signed a letter to members of Congress to urge the passing of a clean Electronic Communications Privacy Act (ECPA) reform bill this year.
Sign-up for Endurance International Signs Letter to Support ECPA Reform investment picks
Endurance International Group (NASDAQ: EIGI ), a leading provider of cloud-based platform solutions to help small and medium-sized businesses succeed online, today announced it has begun to offer Google Apps for Work to its small business subscribers.
Sign-up for Endurance Joins Google Apps for Work Partner Program investment picks
Accenture (NYSE: ACN) announced that Endurance Specialty Holding, Ltd., a global specialty provider of property and casualty (P&C) insurance and reinsurance, has gone into production with Accenture Duck Creek Policy and Rating software to support its diverse worldwide client portfolio.
Sign-up for Endurance Specialty Holding, Ltd. Transitions Policy Administration and Rating Systems to Accenture Duck Creek Software investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Endo to buy Auxilium in $2.6 billion deal to Endurance Specialty Holding, Ltd. Transitions Policy Administration and Rating Systems to Accenture Duck Creek Software
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices